Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Cash & Equivalents: 2022

Historic Cash & Equivalents for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2022 value amounting to $77.3 million.

  • Lexeo Therapeutics' Cash & Equivalents fell 62.35% to $35.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $35.4 million, marking a year-over-year decrease of 62.35%. This contributed to the annual value of $77.3 million for FY2022, which is N/A change from last year.
  • Per Lexeo Therapeutics' latest filing, its Cash & Equivalents stood at $77.3 million for FY2022.
  • Over the past 5 years, Lexeo Therapeutics' Cash & Equivalents peaked at $77.3 million during FY2022, and registered a low of $77.3 million during FY2022.
  • In the last 1 years, Lexeo Therapeutics' Cash & Equivalents had a median value of $77.3 million in 2022 and averaged $77.3 million.